Juvena Therapeutics – Patient Worthy

source: pixabay.com

3 Million Dollar Grant will Support Myotonic Dystrophy Type 1 Research

Post author:Trudy Horsting
Post published:April 4, 2022
Post category:Myotonic Dystrophy

Juvena Therapeutics has just announced that they've received a new grant which will fund their research of myotonic dystrophy type 1 (DM1). This was a very competitive grant which totals…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More